多发大灶性病变是多发性骨髓瘤强有力的独立预后因素
该研究纳入404例适合移植的新诊断多发性骨髓瘤患者,采用背景抑制弥散加权磁共振成像评估灶性病变大小。至少3个垂直直径乘积>5 cm²的大灶性病变见于13.8%的患者,与较差的无进展生存和总生存相关,且独立于RISS、GEP风险评分、gain(1q)或髓外病变。
要点
- 至少3个大灶性病变(垂直直径乘积>5 cm²)见于13.8%的新诊断骨髓瘤患者。
- 该特征与较差的无进展生存和总生存相关,中位分别为2.3年和3.6年。
- 在多因素分析中,该特征独立于RISS、GEP风险评分、gain(1q)和髓外病变。
核心结论
- 至少3个大灶性病变是高危特征,可用于细化该类疾病行为的诊断,并作为风险分层试验的入组标准。
研究设计与样本
- 研究纳入404例适合移植的新诊断多发性骨髓瘤患者,采用背景抑制弥散加权磁共振成像评估灶性病变大小。
主要发现
- 至少3个垂直直径乘积>5 cm²的大灶性病变见于13.8%的患者,与较差的无进展生存和总生存相关,中位分别为2.3年和3.6年。
- 在多因素分析中,该特征独立于RISS、GEP风险评分、gain(1q)或髓外病变,无进展生存和总生存的风险比分别为2.7和2.2。
- 校正灶性病变大小后,灶性病变数量对结局的负面影响消失。
临床怎么用
- 作者认为,至少3个大灶性病变是高危特征,可用于细化该类疾病行为的诊断,并作为风险分层试验的入组标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Spatial intratumor heterogeneity is frequently seen in multiple myeloma (MM) and poses a significant challenge for risk classifiers, which rely on tumor samples from the iliac crest. Because biopsy-based assessment of multiple skeletal sites is difficult, alternative strategies for risk stratification are required. Recently, the size of focal lesions (FLs) was shown to be a surrogate marker for spatial heterogeneity, suggesting that data from medical imaging could be used to improve risk stratification approaches. Here, we investigated the prognostic value of FL size in 404 transplant-eligible, newly diagnosed MM patients. Using diffusion-weighted magnetic resonance imaging with background suppression, we identified the presence of multiple large FLs as a strong prognostic factor. Patients with at least 3 large FLs with a product of the perpendicular diameters >5 cm2 were associated with poor progression-free survival (PFS) and overall survival (OS; median, 2.3 and 3.6 years, respectively). This pattern, seen in 13.8% of patients, was independent of the Revised International Staging System (RISS), gene expression profiling (GEP)-based risk score, gain(1q), or extramedullary disease (hazard ratio, 2.7 and 2.2 for PFS and OS in multivariate analysis, respectively). The number of FLs lost its negative impact on outcome after adjusting for FL size. In conclusion, the presence of at least 3 large FL is a feature of high risk, which can be used to refine the diagnosis of this type of disease behavior and as an entry criterion for risk-stratified trials.
引用
- Rasche L, Angtuaco EJ, Alpe TL, et al. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood. 2018. PMID: 29784643. doi:10.1182/blood-2018-04-842880
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。